SpinChip Diagnostics (www.spinchip.no) is developing a game changing and proprietary platform for in vitro diagnostics point of care analyses. The platform will make it possible to perform a broader range of analyses using one platform and to transfer analyses from central laboratories to point of care without loss in quality. All analyses are performed within a few minutes based on a fraction of a droplet of blood and at a unit cost significantly lower than other point of care platforms. Our initial focus is on rapid cardiac markers with troponin-i (a marker for myocardial infarction) as the pilot application.
Medical device —